Literature DB >> 3805275

Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.

A B Bjornson, J S Lobel.   

Abstract

Two approaches were used to demonstrate that reduction in serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in children with sickle cell disease is related to a deficiency of antibodies to pneumococcal capsular polysaccharide. First, opsonization of S. pneumoniae mediated by the alternative pathway in patients' sera was restored to normal by addition of the purified IgG or IgM fraction of goat antiserum to capsular polysaccharide of the homologous serotype. Secondly, IgG antibody titers to capsular polysaccharide in patients' sera correlated significantly with alternative pathway-mediated opsonization; the correlation between titers of IgM anticapsular antibodies and opsonization approached statistical significance. The sum of the IgG and IgM anticapsular antibody titers correlated most significantly with opsonization. Our results suggest that reduction in alternative pathway-mediated opsonization in sera from children with sickle cell disease is related to low levels of both IgG and IgM anticapsular antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805275      PMCID: PMC424081          DOI: 10.1172/JCI112824

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils.

Authors:  D A Lawrence; W O Weigle; H L Spiegelberg
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

4.  Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.

Authors:  G S Giebink; J E Foker; Y Kim; G Schiffman
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

5.  An abnormality of the alternate pathway of complement activation in sickle-cell disease.

Authors:  R B Johnston; S L Newman; A G Struth
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

Review 6.  Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature.

Authors:  E Barrett-Connor
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

7.  The bactericidal and opsonic effects of serum from patients with sickle cell anaemia.

Authors:  N K Luo; H A Rowland
Journal:  Bull Soc Pathol Exot Filiales       Date:  1983-11

8.  IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma.

Authors:  I S Aaberge; H E Heier; E Hem; K E Giercksky; E C Groeng
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-02

9.  Evidence for presence of an internal thiolester bond in third component of human complement.

Authors:  B F Tack; R A Harrison; J Janatova; M L Thomas; J W Prahl
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.

Authors:  A B Bjornson; J S Lobel; K S Harr
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

View more
  10 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults.

Authors:  J E Lortan; A S Kaniuk; M A Monteil
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

3.  Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.

Authors:  A Nowak-Wegrzyn; J A Winkelstein; A J Swift; H M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

4.  IgG subclasses and complement pathway in segmental and global membranous nephropathy.

Authors:  Yoshie Segawa; Satoshi Hisano; Misao Matsushita; Teizo Fujita; Shinichi Hirose; Morishige Takeshita; Hiroshi Iwasaki
Journal:  Pediatr Nephrol       Date:  2010-02-12       Impact factor: 3.714

5.  Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide.

Authors:  Z Zhong; T Burns; Q Chang; M Carroll; L Pirofski
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Allogeneic haematopoietic stem cell transplantation resets T- and B-cell compartments in sickle cell disease patients.

Authors:  Luciana Ribeiro Jarduli-Maciel; Júlia Teixeira Cottas de Azevedo; Emmanuel Clave; Thalita Cristina de Mello Costa; Lucas Coelho Marlière Arruda; Isabelle Fournier; Patrícia Vianna Bonini Palma; Keli Cristina Lima; Juliana Bernardes Elias; Ana Beatriz Pl Stracieri; Fabiano Pieroni; Renato Cunha; Luiz Guilherme Darrigo-Júnior; Carlos Eduardo Settani Grecco; Dimas Tadeu Covas; Ana Cristina Silva-Pinto; Gil Cunha De Santis; Belinda Pinto Simões; Maria Carolina Oliveira; Antoine Toubert; Kelen Cristina Ribeiro Malmegrim
Journal:  Clin Transl Immunology       Date:  2022-04-23

7.  Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci.

Authors:  Q Chang; Z Zhong; A Lees; M Pekna; L Pirofski
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease.

Authors:  Woelsung Yi; Weili Bao; Marilis Rodriguez; Yunfeng Liu; Manpreet Singh; Vijendra Ramlall; Jeny R Cursino-Santos; Hui Zhong; Catherine M Elton; Gavin J Wright; Avital Mendelson; Xiuli An; Cheryl A Lobo; Karina Yazdanbakhsh
Journal:  Blood Adv       Date:  2018-12-11

9.  Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.

Authors:  Steven M Szczepanek; Sean Roberts; Kara Rogers; Christina Cotte; Alexander J Adami; Sonali J Bracken; Sharon Salmon; Eric R Secor; Roger S Thrall; Biree Andemariam; Dennis W Metzger
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

10.  Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination.

Authors:  Steven M Szczepanek; Eric R Secor; Sonali J Bracken; Linda Guernsey; Ektor Rafti; Adam Matson; Roger S Thrall; Biree Andemariam
Journal:  Pediatr Res       Date:  2013-05-31       Impact factor: 3.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.